Abstract
The aim of this research was to explore the effects and signaling pathway of ultraviolet-B (UVB) irradiation on the expression of hypoxia-inducible factor 1α (HIF-1α) and transferrin receptor (TfR). HIF-1α protein was measured by Western blot method. Expressions of epidermal growth factor receptor (EGFR), phosphor-EGF-R and TfR after UVB irradiation were determined with flow cytometry. After UVB irradiation, mRNA levels of HIF-1α and TfR were detected by real time-PCR. Results showed that compared with control groups, UVB was able to induce HIF1α and TfR protein expression in a dose-and time-dependent manner in HaCat cells (P < 0.05). TfR mRNA was expressed in a dose-dependent manner and reached a peak at the 8th hour in HaCat cells (P < 0.05) whereas HIF-1α mRNA expression was not affected by UVB treatment (P>0.05). The EGFR/PI3K/AKT signaling pathway was required for the induction of HIF-1α and TfR expression induced by UVB. UVB induced activation of EGFR in HaCat cells and EGFR regulated expression of TfR and HIF-1α. EGFR (−/−) MEF did not increase the HIF1 expression following UVB irradiation (P>0.05). In contrast, EGFR (+/+) MEF strongly enhanced HIF1α expression after UVB irradiation (P < 0.05). PD153035, a selective inhibitor of EGFR tyrosine kinase, inhibited the TfR protein expression in UVB-treated cells in a dose-dependent manner (P < 0.05). PI3K inhibitors, LY294002 and wortmannin, inhibited HIF-1α and TfR expressions induced by UVB (P < 0.05). The DEC1 (−/−) HaCat cells did not increase their TfR and HIF-1α expressions following UVB irradiation (P>0.05). In contrast, DEC1 (+/+) HaCat cells strongly enhanced TfR and HIF-1α protein expression after UVB irradiation (P < 0.05). We conclude that UVB induces TfR and HIF-1α expressions via EGFR/PI3K/AKT/DEC1 signaling pathway.
Similar content being viewed by others
References
Epstein J H. Photocarcinogenesis, skin cancer, and aging. J Am Acad Dermatol, 1983, 9(4): 487–502
Fisher G J, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, Voorhees J J. Mechanisms of photoaging and chronological skin aging. Arch Dermatol, 2002, 138(11): 1462–1470
Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T. UV-induced skin damage. Toxicology, 2003, 189(1–2): 21–39
de Gruijl F R. p53 mutations as a marker of skin cancer risk: comparison of UVA and UVB effects. Exp Dermatol, 2002, 11Suppl 1: 37–39
Miller C C, Hale P, Pentland A P. Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation. J Biol Chem, 1994, 269(5): 3529–3533
Wan Y S, Wang Z Q, Shao Y, Voorhees J J, Fisher G J. Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int J Oncol, 2001, 18(3): 461–466
Zhang Q S, Maddock D A, Chen J P, Heo S, Chiu C, Lai D, Souza K, Mehta S, Wan Y S. Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes. Int J Oncol, 2001, 19(5): 1057–1061
Hess A R, Seftor E A, Seftor, R E, Hendrix M J. Phosphoinositide 3-Kinase Regulates Membrane Type 1-Matrix Metalloproteinase (MMP) and MMP-2 Activity during Melanoma Cell Vasculogenic Mimicry. Cancer Res, 2003, 63(16): 4757–4762
Youn J I, Gange R W, Maytum D, Parrish J A. Effect of hypoxia on sunburn cell formation and inflammation induced by ultraviolet radiation. Photodermatol, 1988, 5(6): 252–256
Tacchini L, Bianchi L, Bernelli-Zazzera A, Cairo G. Transferrin receptor induction by hypoxia HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem, 1999, 274(34): 24142–24146
Jiang B H, Rue E, Wang G L, Roe R, Semenza G L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem, 1996, 271(30): 17771–17778
Hoffman E C, Reyes H, Chu F F, Sander F, Conley L H, Brooks B A, Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science, 1991, 252(5008): 954–958
Forsythe J A, Jiang B H, Iyer N V, Agani F, Leung S W, Koos R D, Semenza G L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol, 1996, 16(9): 4604–4613
Lee P J, Jiang B H, Chin B Y, Iyer N V, Alarn J, Semenza G L, Choi A M. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem, 1997, 272(9): 5375–5381
Semenza G L, Jiang B H, Leung S W, Passangtino R, Concordet J P, Maire P, Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem, 1996, 271(51): 32529–32537
Semenza G L, Agani F, Booth G, Forsythe J, Iyer N, Jiang B H, Leung S, Roe R, Wiener C, Yu A. Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int, 1997, 51(2): 553–555
Maxwell P H, Dachs G U, Gleadle J M, Nicholls L G, Harris A L, Stratford I J, Hankinson O, Pugh C W, Ratcliffe P J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA, 1997, 94(15): 8104–8109
Zhong H, De Marzo A M, Laughner E, Lim M, Hilton D A, Zagzag D, Buechler P, Isaacs W B, Semenza G L, Simons J W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 1999, 59(22): 5830–5835
Jiang B H, Jiang G, Zheng J Z, Lu Z, Hunter T, Vogt P K. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ, 2001, 12(7): 363–369
Minet E, Amould T, Michel G, Roland I, Mottet D, Raes M, Remacle J, Michiels C. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett, 2000, 468(1): 53–58
Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu M M, Simons J W, Semenza G L. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res, 2000, 60(6): 1541–1545
Tanaka N, Sugihara K, Odajima T, Mimura M, Kimijima Y, Ichinose S. Oral squamous cell carcinoma: electron microscopic and immunohistochemical characteristics. Med Electron Microse, 2002, 35(3): 127–138
Shinohara H, Fan D, Ozawa S, Yano S, Van Arsdell M, Viner J L, Beers R, Pastan I, Fidler I J. Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin. Int J Oncol, 2000, 17(4): 643–645
Kemp J D. Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor. Histol Histopathol, 1997, 12(1): 291–296
Yamada K, Miyamoto K. Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3, their gene expressions are regulated by multiple extracellular stimuli. Front Biosci, 2005, 10: 3151–3171
Shen M, Kawamoto T, Teramoto M, Makihira S, Fujimoto K, Yan W, Noshiro M, Kato Y. Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway. Eur J Cell Biol, 2001, 80(5): 329–334
Wang H Q, Smart R C. Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. J Cell Sci, 1999, 112(Pt 20): 3497–3506
Kallio P J, Wilson W J, O’Brien S, Makino Y, Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem, 1999, 274(10): 6519–6525
Sandau K B, Fandrey J, Brune B. Accumulation of HIF-1alpha under the influence of nitric oxide. Blood, 2001, 97(4): 1009–1015
Cockman M E, Masson N, Mole D R, Jaakkola P, Chang G W, Clifford S C, Maher E R, Pugh C W, Ratcliffe P J, Maxwell P H. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem, 2000, 275(33): 25733–25741
Ryschich E, Huszty G, Knaebel H P, Hartel M, Buchler M W, Schmidt J. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur J Cancer, 2004, 40(9): 1418–1422
Bruick R K, McKnight S L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 2001, 294(5545): 1337–1340
Khatua S, Peterson K M, Brown K M, Lawlor C, Santi M R, LaFleur B, Dressman D, Stephan D A, MacDonald T J. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res, 2003, 63(8): 1865–1870
Pili R, Donehower R C. Is HIF-1 alpha a valid therapeutic target? J Natl Cancer Inst, 2003, 95(7): 498–499.
Yeo E J, Chun Y S, Cho Y S, Kim J, Lee J C, Kim M S, Park J W. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst, 2003, 95(7): 516–525
Fujimoto K, Shen M, Noshiro M, Matsubara K, Shingu S, Honda K, Yoshida E, Suardita K, Matsuda Y, Kato Y. Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins. Biochem Biophys Res Commun, 2001, 280(1): 164–171
Shen M, Kawamoto T, Yan W, Nakamasu K, Tamagami M, Koyano Y, Noshiro M, Kato Y. Molecular characterization of the novel basichlelix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. Biochem Biophys Res Commun, 1997, 236(2): 294–298
Ivanova A V, Ivanov S V, Danilkovitch-Miagkova A, Lerman M I. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway. J Biol Chem, 2001, 276(18): 15306–15315
Li Y, Zhang H, Xie M, Hu M, Ge S, Yang D, Wan Y, Yan B. Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem J, 2002, 367(Pt 2): 413–422
Li Y, Xie M, Song X, Gragen S, Sachdeva K, Wan Y, Yan B. DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter. J Biol Chem, 2003, 278(19): 16899–16907
Giatromanolaki A, Koukourakis M I, Sivridis E, Turley H, Wykoff C C, Gatter K C, Harris A L DEC1 (STRA13) protein expression relates to hypoxia-inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol, 2003, 200(2): 222–228
Miyazaki K, Kawamoto T, Tanimoto K, Nishiyama M, Honda H, Kato Y. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem, 2002, 277(49): 47014–47021
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, Y., Bi, Z. Ultravlolet-B induced expression of hypoxia-inducible factor 1α, transferrin receptor through EGFR/PI3K/AKT/DEC1 pathway. Front. Med. China 1, 79–86 (2007). https://doi.org/10.1007/s11684-007-0016-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-007-0016-4